Who Owns NewAmsterdam Pharma Company N.V. (NAMS)?Hedge Fund & Institutional Holders
Institutional Holders
50
as of Q4 2025
Total Institutional Value
$InfinityT
% of Float Held
Infinity%
QoQ Change in Holders
+3 / -3
Price History
NAMS — Biggest New Institutional Buyers This Quarter
| Fund | Action | Shares Added | Value Added |
|---|---|---|---|
| FMR LLC | Increased | +878K | +$221.8B |
| JENNISON ASSOCIATES LLC | New Position | +3.5M | +$122.4B |
| Frazier Life Sciences Management, L.P. | Increased | +242K | +$122.3B |
| Capital World Investors | Increased | +161K | +$70.6B |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | +1.0M | +$58.7B |
| GOLDMAN SACHS GROUP INC | Increased | +845K | +$35.0B |
| MAVERICK CAPITAL LTD | Increased | +389K | +$23.2B |
| JANUS HENDERSON GROUP PLC | Increased | +225K | +$20.9B |
| Ensign Peak Advisors, Inc | New Position | +550K | +$19.0B |
| Logos Global Management LP | New Position | +450K | +$15.8B |
| CITADEL ADVISORS LLC | Increased | +429K | +$15.1B |
| FRANKLIN RESOURCES INC | Increased | +363K | +$14.5B |
| Artia Global Partners LP | Increased | +309K | +$12.1B |
| First Turn Management, LLC | Increased | +177K | +$11.0B |
| UBS Group AG | Increased | +131K | +$9.7B |
NAMS — Institutions Reducing or Closing Positions
| Fund | Action | Shares Sold | Value Sold |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Decreased | -589K | -$293.7B |
| Bain Capital Life Sciences Investors, LLC | Decreased | -3.4M | -$47.9B |
| VIKING GLOBAL INVESTORS LP | Decreased | -2.3M | -$36.7B |
| Cormorant Asset Management, LP | Decreased | -1.2M | -$26.8B |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Decreased | -1.2M | -$24.3B |
| Siren, L.L.C. | Closed Position | -766K | -$21.8B |
| ALLIANCEBERNSTEIN L.P. | Decreased | -841K | -$15.9B |
| Woodline Partners LP | Decreased | -407K | -$6.9B |
| AXA Investment Managers S.A. | Closed Position | -197K | -$5.6B |
| Saturn V Capital Management LP | Closed Position | -153K | -$4.4B |
| JPMORGAN CHASE & CO | Decreased | -303K | -$4.0B |
| Ikarian Capital, LLC | Decreased | -61K | -$3.0B |
| Invesco Ltd. | Decreased | -99K | -$2.8B |
| CenterBook Partners LP | Decreased | -59K | -$2.0B |
| STEMPOINT CAPITAL LP | Decreased | -77K | -$1.7B |
Top Institutional Holders(Q4 2025)
| # | Fund | Shares | Value | % of Portfolio | Type |
|---|---|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 16,943,774 | $594.4B | 15.96% | Share |
| 2 | Capital World Investors | 9,984,000 | $350.0B | 47.60% | Share |
| 3 | Bain Capital Life Sciences Investors, LLC | 7,306,566 | $256.3B | 19.63% | Share |
| 4 | FMR LLC | 5,498,198 | $192.0B | 9.79% | Share |
| 5 | WELLINGTON MANAGEMENT GROUP LLP | 4,701,398 | $164.0B | 28.74% | Share |
| 6 | FCPM III SERVICES B.V. | 4,648,025 | $163.1B | 21.37% | Share |
| 7 | FCPM III SERVICES B.V. | 4,550,875 | $159.6B | 20.93% | Share |
| 8 | VIKING GLOBAL INVESTORS LP | 4,203,567 | $147.5B | 391.37% | Share |
| 9 | DEERFIELD MANAGEMENT COMPANY, L.P. | 4,164,789 | $146.1B | 1865.86% | Share |
| 10 | JENNISON ASSOCIATES LLC | 2,967,825 | $104.1B | 62.50% | Share |
| 11 | Polar Capital Holdings Plc | 2,776,222 | $97.0B | 374.85% | Share |
| 12 | JANUS HENDERSON GROUP PLC | 2,320,346 | $81.0B | 36.27% | Share |
| 13 | MAVERICK CAPITAL LTD | 1,894,226 | $66.0B | 708.46% | Share |
| 14 | GOLDMAN SACHS GROUP INC | 1,664,734 | $58.0B | 7.15% | Share |
| 15 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,406,631 | $49.0B | 74.16% | Share |
| 16 | ALLIANCEBERNSTEIN L.P. | 1,300,875 | $45.0B | 14.21% | Share |
| 17 | Cormorant Asset Management, LP | 1,000,000 | $35.1B | 1.62% | Share |
| 18 | First Turn Management, LLC | 893,473 | $31.3B | 3.58% | Share |
| 19 | JPMORGAN CHASE & CO | 829,529 | $29.0B | 1.82% | Share |
| 20 | TimesSquare Capital Management, LLC | 822,300 | $28.8B | 434.53% | Share |
| 21 | FRANKLIN RESOURCES INC | 762,298 | $26.0B | 6.38% | Share |
| 22 | Woodline Partners LP | 751,270 | $26.0B | 100.74% | Share |
| 23 | Aberdeen Group plc | 729,484 | $25.6B | 39.62% | Share |
| 24 | UBS Group AG | 703,492 | $24.7B | 4.00% | Share |
| 25 | AMERICAN CENTURY COMPANIES INC | 603,401 | $21.0B | 10.55% | Share |
| 26 | Decheng Capital LLC | 592,057 | $20.8B | 2.79% | Share |
| 27 | Rock Springs Capital Management LP | 557,194 | $19.5B | 1.00% | Share |
| 28 | Ensign Peak Advisors, Inc | 549,511 | $19.0B | 33.56% | Share |
| 29 | JENNISON ASSOCIATES LLC | 521,396 | $18.3B | 10.98% | Share |
| 30 | Artia Global Partners LP | 503,936 | $17.7B | 2.50% | Share |
| 31 | Logos Global Management LP | 450,000 | $15.8B | 0.95% | Share |
| 32 | Eversept Partners, LP | 420,827 | $14.8B | 0.74% | Share |
| 33 | FMR LLC | 376,682 | $13.0B | 0.66% | Share |
| 34 | FMR LLC | 370,260 | $12.0B | 0.61% | Share |
| 35 | BANK OF AMERICA CORP /DE/ | 351,504 | $12.0B | 0.87% | Share |
| 36 | Frazier Life Sciences Management, L.P. | 500,333 | $11.5B | 0.31% | Share |
| 37 | Slate Path Capital LP | 319,000 | $11.2B | 150.92% | Share |
| 38 | CITADEL ADVISORS LLC | 340,357 | $11.0B | 1.65% | Share |
| 39 | ArrowMark Colorado Holdings LLC | 298,077 | $10.5B | 0.23% | Share |
| 40 | CITADEL ADVISORS LLC | 294,890 | $10.0B | 1.50% | Share |
| 41 | Affinity Asset Advisors, LLC | 275,000 | $9.6B | 0.55% | Share |
| 42 | FIRST TRUST ADVISORS LP | 279,701 | $9.0B | 6.54% | Share |
| 43 | GILDER GAGNON HOWE & CO LLC | 248,528 | $8.7B | 92.02% | Share |
| 44 | MILLENNIUM MANAGEMENT LLC | 254,596 | $8.0B | 3.36% | Share |
| 45 | Nicholas Investment Partners, LP | 213,419 | $7.5B | 0.55% | Share |
| 46 | WELLINGTON MANAGEMENT GROUP LLP | 226,895 | $7.0B | 1.23% | Share |
| 47 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 201,300 | $7.0B | 0.81% | Put |
| 48 | Atle Fund Management AB | 197,036 | $6.9B | 2.21% | Share |
| 49 | UBS Group AG | 191,100 | $6.7B | 1.09% | Share |
| 50 | KENNEDY CAPITAL MANAGEMENT LLC | 172,931 | $6.1B | 0.13% | Share |
NAMS Institutional Ownership History
| Quarter | Holders | Total Value | Change |
|---|---|---|---|
| Q4 2025 | 185 | $3.3T | +73 |
| Q3 2025 | 112 | $2.9T | +2 |
| Q2 2025 | 110 | $1.6T | -21 |
| Q1 2025 | 131 | $2.1T | -5 |
| Q4 2024 | 136 | $3.0T | +41 |
| Q3 2024 | 95 | $7.5T | +11 |
| Q2 2024 | 84 | $1.8T | +8 |
| Q1 2024 | 76 | $3.9T | — |
Similar Stocks by Institutional Ownership
As of Q4 2025, 50 institutional investors hold NAMS (NewAmsterdam Pharma Company N.V.). The largest holder is Frazier Life Sciences Management, L.P. with $594.4B in shares. This quarter, 3 institutions opened new positions and 3 closed their positions.
Frequently Asked Questions
How many hedge funds own NAMS?
As of Q4 2025, 50 institutional investors report holding NAMS (NewAmsterdam Pharma Company N.V.) in their 13F filings.
Who is the largest institutional holder of NAMS?
The largest institutional holder of NAMS is Frazier Life Sciences Management, L.P. with $594.4B in shares.
Is institutional ownership of NAMS increasing or decreasing?
This quarter, 3 institutions opened new positions in NAMS and 3 closed their positions.